Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and alzheimer's disease

Journal of Alzheimer's Disease

Volumn 16, Issue 3, 2009, Pages 467-470

  Panza, Francesco ^a   Frisardi, Vincenza ^a   Capurso, Cristiano ^b   D'Introno, Alessia ^a   Colacicco, Anna M ^a   Vendemiale, Gianluigi ^b,c   Capurso, Antonio ^a   Solfrizzi, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c IRCSS Casa Sollievo Dalla Sofferenza   (Italy)

Author keywords

Alzheimer's disease; Mild cognitive impairment; S Adenosylhomocysteine; S Adenosylmethionine; 3 polyunsturated fatty acids

Indexed keywords

ARACHIDONIC ACID; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PLACEBO; POLYUNSATURATED FATTY ACID; PYRIDOXINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; VITAMIN B GROUP; UNSATURATED FATTY ACID;

ALZHEIMER DISEASE; ARTICLE; BRAIN PROTECTION; CALORIC INTAKE; CLINICAL TRIAL; COGNITION; DIET SUPPLEMENTATION; DRUG ACTIVITY; HUMAN; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONOTHERAPY; ORGANIC BRAIN SYNDROME; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; DEMENTIA; LETTER; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; DEMENTIA; FATTY ACIDS, UNSATURATED; HUMANS; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE;

EID: 65549120331     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1012     Document Type: Article

References (23)

1. Tchantchou F, Graves M, Falcone D, Shea TB (2008) S-adenosylmethionine mediates glutathione efficacy by increasing glutathione S-transferase activity: implications for S-adenosyl methionine as a neuroprotective dietary supplement. J Alzheimers Dis 14, 323-328.
2. Tchantchou F, Graves M, Ortiz D, Shea TB (2006) S-adenosyl methionine: a link between nutritional and genetic risk factors in Alzheimer's disease. J Nutr Health Aging 10, 541-544.
3. Morozova N, Khrapko K, Panee J, Liu W, Harney JW, Berry MJ (2007) Glutathione depletion in hippocampal cells increases levels of H and L ferritin and glutathione S-transferase mRNAs. Genes Cells 12, 561-567.
4. Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acidreactive substances and antioxi-dant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
5. Lovell MA, Xie C, Markesbery WR (1998) Decreased glu-tathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566.
6. Chan A, Shea TB (2007) Improved cognitive performance and decreased aggression in normal and ApoE4 mice following dietary supplementation with N-acetyl cysteine, acetyl-Lcarnitine and S-adenosyl methionine. Neuromol Med 9, 264-269.
7. Chan A, Tchantchou F, Graves V, Rozen R, Shea TB (2008) Dietary and genetic compromise in folate availability reduces acetylcholine and cognitive performance: critical role of S-adenosylmethionine. J Health Nutr Aging 12, 252-261.
8. Selley ML (2007) A metabolic link between S-adenosyl-homocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol Aging 28, 1834-1839.
9. Panza F, Capurso C, D'Introno A, Colacicco AM, Capurso A, Solfrizzi V (2008) S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease. Neurobiol Aging 29, 478-480.
10. Watkins SM, Zhu X, Zeisel SH (2003) Phosphatidylethanol amine-Nmethyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. J Nutr 133, 3386-3391.
11. Solfrizzi V, D'Introno A, Colacicco AM, Capurso C,Todarello O, Pellicani V, Capurso SA, Pietrarossa G, Santamato V, Capurso A, Panza F (2006) Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta 364, 91-112.
12. Panza F, Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Torres F, Del Parigi A, Capurso S, Capurso A (2004) Mediterranean diet and cognitive decline. Public Health Nutr 7, 959-963.
13. Panza F, Capurso C, D'Introno A, Colacicco AM, Chirico M, Capurso A, Solfrizzi V (2007) Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer's disease. J Am Geriatr Soc 55, 469-470.
14. Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Santamato A, Ranieri M, Fiore P, Vendemiale G, Seripa D, Pilotto A, Capurso A, Panza F (2008) Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment. J Nutr Health Aging 12, 382-386.
15. Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Torres F, Rizzo C, Capurso A, Panza F (2006) Dietary intake of unsaturated fatty acids and age-related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging 27, 1694-1704.
16. SolfrizziV,Colacicco AM, D'IntronoA,CapursoC,Del Parigi A, Capurso SA, Argentieri G, Capurso A, Panza F (2005) Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp Gerontol 40, 257-270.
17. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006) ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind trial. Arch Neurol 263, 1402-1408.
18. Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M (2008) Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry 23, 161-169.
19. Irving GF, Freund-Levi Y, Eriksdotter-Jönhagen M, Basun H, Brismar K, Hjorth E, Palmblad J, Vessby B, Vedin I, Wahlund LO, Cederholm T (2009) Omega-3 Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer's Disease: The Omega-3 Alzheimer's Disease Study. J Am Geriatr Soc 57, 11-17.
20. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T (2006) Dietary supplementation of arachidonic and docosa-hexaenoic acids improves cognitive dysfunction. Neurosci Res 56, 159-164.
21. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32, 1538-1544
22. Richardson AJ, Allen SJ, Hajnal JV, Cox IJ, Easton T, Puri BK (2001) Associations between central and peripheral measures of phospholipids breakdown revealed by cerebral 31-phosophorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Prog Neuropsychopharmacol Biol Psychiatry 25, 1513-1521.
23. Del Parigi A, Panza F, Capurso C, Solfrizzi V (2006) Nutritional factors, cognitive decline, and dementia. Brain Res Bull 69, 1-19.